? BIOINFORMATICS SHARED RESOURCE The Bioinformatics Shared Resource (BSR) provides Cancer Center (CC) members with access to state-of- the-art technology for analysis of high dimensional datasets involving next-generation sequencing, microarray, proteome and metabolome platforms, as well as integration of multi-omics results. The BSR develops algorithms, computational tools and databases ideally suited for the quantitative analysis of a wide variety of experimental questions in cancer research. Services offered by the BSR include: (i) statistical analyses and computational modeling; (ii) development of advanced bioinformatics tools for integrative cancer biology; and (iii) data management. The BSR has undergone significant growth in expertise and capabilities during the last Cancer Center Support Grant (CCSG) budget cycle. This was in response to the large thematic faculty recruitment in the CC, the expansion of computational-intensive research themes (cancer metabolism, phenotype profiling) and the growing need for high-dimensional data analysis across multiple technologies. Rehman Qureshi, Ph.D., Harsh Dweep, Ph.D. and Hideki Tanizawa, Ph.D. were recruited to the BSR staff during the last CCSG budget cycle to expand computational expertise; Wen-Hwai Horng, M.S. led the synergistic integration of system administration with a reorganized Wistar Information Technology (IT) Department, and a data analysis pipeline was developed synergistically with the Genomics, Proteomics and Molecular Screening Shared Resources to ensure seamless flow of data and appropriate quality control, feedback and troubleshooting. BSR staff and the Scientific Director are located within dry laboratory space in the Center for Systems and Computational Biology, next to Biostatistics faculty and post-doctoral fellows with strong interests in computational biology. The central location of the BSR facilitates scientific exchange and collaborations, thereby increasing the overall level of analytic approaches and quality of results. During the last CCSG budget cycle, CC members from all three Programs have extensively utilized BSR services contributing to a broad portfolio of cancer-related publications and grant awards. As an additional measure of the critical impact of its services, the BSR engages in productive collaborations with neighboring academic Institutions and Cancer Centers including the University of Pennsylvania, Children?s Hospital of Philadelphia (CHOP), Fox Chase Cancer Center, Lankenau Institute for Medical Research, and Drexel University. The expansion and refinement of bioinformatics tools of the last CCSG budget cycle have ideally positioned the BSR for state-of- the-art management of complex datasets and emerging technologies in sync with the recent CC expansion.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA010815-51
Application #
9917705
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-03-01
Budget End
2021-02-28
Support Year
51
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Wistar Institute
Department
Type
DUNS #
075524595
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Li, Heng; Wang, Zhize; Xiao, Wei et al. (2018) Androgen-receptor splice variant-7-positive prostate cancer: a novel molecular subtype with markedly worse androgen-deprivation therapy outcomes in newly diagnosed patients. Mod Pathol 31:198-208
Shastrula, Prashanth K; Rice, Cory T; Wang, Zhuo et al. (2018) Structural and functional analysis of an OB-fold in human Ctc1 implicated in telomere maintenance and bone marrow syndromes. Nucleic Acids Res 46:972-984
Duperret, Elizabeth K; Trautz, Aspen; Ammons, Dylan et al. (2018) Alteration of the Tumor Stroma Using a Consensus DNA Vaccine Targeting Fibroblast Activation Protein (FAP) Synergizes with Antitumor Vaccine Therapy in Mice. Clin Cancer Res 24:1190-1201
Heppt, Markus V; Wang, Joshua X; Hristova, Denitsa M et al. (2018) MSX1-Induced Neural Crest-Like Reprogramming Promotes Melanoma Progression. J Invest Dermatol 138:141-149
Wu, Shuai; Fatkhutdinov, Nail; Fukumoto, Takeshi et al. (2018) SWI/SNF catalytic subunits' switch drives resistance to EZH2 inhibitors in ARID1A-mutated cells. Nat Commun 9:4116
Ecker, Brett L; Kaur, Amanpreet; Douglass, Stephen M et al. (2018) Age-Related Changes in HAPLN1 Increase Lymphatic Permeability and Affect Routes of Melanoma Metastasis. Cancer Discov :
Abdel-Mohsen, Mohamed; Kuri-Cervantes, Leticia; Grau-Exposito, Judith et al. (2018) CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells. Sci Transl Med 10:
Fukumoto, Takeshi; Magno, Elizabeth; Zhang, Rugang (2018) SWI/SNF Complexes in Ovarian Cancer: Mechanistic Insights and Therapeutic Implications. Mol Cancer Res 16:1819-1825
Cañadas, Israel; Thummalapalli, Rohit; Kim, Jong Wook et al. (2018) Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses. Nat Med 24:1143-1150
Basu, Subhasree; Gnanapradeepan, Keerthana; Barnoud, Thibaut et al. (2018) Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1?. Genes Dev 32:230-243

Showing the most recent 10 out of 741 publications